+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Acadia Pharmaceuticals Inc - logo

Acadia Pharmaceuticals is a biopharmaceutical company that focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. Its lead product candidate, NUPLAZID, has completed the Phase III pivotal trials for the treatment of Parkinson's disease, Phase II trial for the treatment of schizophrenia and Phase II study for the treatment of Alzheimer's disease. The company was founded in 1993 and is headquartered in San Diego, California.

Rare Diseases Treatment Market - Global Forecast 2025-2032 - Product Thumbnail Image

Rare Diseases Treatment Market - Global Forecast 2025-2032

  • Report
  • November 2025
  • 196 Pages
  • Global
From
Dry Eye Syndrome Market Report 2025 - Product Thumbnail Image

Dry Eye Syndrome Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
From
Drug Discovery Technologies - Global Strategic Business Report - Product Thumbnail Image

Drug Discovery Technologies - Global Strategic Business Report

  • Report
  • November 2025
  • 486 Pages
  • Global
From
Pimavanserin Drugs Market - Global Forecast 2025-2030 - Product Thumbnail Image

Pimavanserin Drugs Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 192 Pages
  • Global
From
From
Malignant Pleural Mesothelioma- Pipeline Insight, 2025 - Product Thumbnail Image

Malignant Pleural Mesothelioma- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Extractables and Leachables Testing Services Market, 2018-2028 - Product Thumbnail Image

Extractables and Leachables Testing Services Market, 2018-2028

  • Report
  • September 2018
  • 200 Pages
  • Global
From
From
From
Loading Indicator